ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour

Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling

(2009) Amanda Mikels et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of insulin-like growth factor 2 in mesenchymal neoplasms

(2009) Sonja E Steigen et al.   MODERN PATHOLOGY

Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling

(2009) M Enomoto et al.   ONCOGENE

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

(2009) T M Wright et al.   ONCOGENE

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

(2009) M P O’Connell et al.   ONCOGENE

Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers

(2009) Andrew H. Beck et al.   VIRCHOWS ARCHIV

Specific Mutations in the β-Catenin Gene (CTNNB1) Correlate with Local Recurrence in Sporadic Desmoid Tumors

(2008) Alexander J.F. Lazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas

(2008) C.-H. Lee et al.   CLINICAL CANCER RESEARCH

Receptor Tyrosine Kinase Ror2 Mediates Wnt5a-induced Polarized Cell Migration by Activating c-Jun N-terminal Kinase via Actin-binding Protein Filamin A

(2008) Akira Nomachi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY